Abstract:Gut microbiome fermentation of prebiotic fibre increases short-chain fatty acids (SCFA), which can stimulate mucosal B-cells to express secretory IgA in distant tissues (1,2) , and can support gut barrier function. Secretory IgA levels have been associated with reduced upper-respiratory tract infections incidence in immune-compromised populations (3,4) . However, it is not known if prebiotic supplementation would be effective in healthy adults. This study investigated whether inulin can increase mucosal immunity (sIgA) and intestinal permeability markers, alongside acceptability of intervention. Healthy adults (n = 23, BMI: 23.85 ± 3.2 kg.m -2 , age: 33.4 ± 10.1 years) took part in this randomisedcontrolled cross-over trial. Participants were randomly allocated to inulin syrup (12g/day) or placebo syrup (20% diluted honey) for 2-weeks. This was followed by 2-weeks wash-out, and then conditions were switched for a final 2-week supplementation. Before and after each supplementation, faecal pH was measured with glass probe, and salivary sIgA and plasma lipopolysaccharide binding protein (LBP, marker of intestinal permeability) were measured with ELISA kits. Time to provide 2ml of saliva through passive drooling was recorded, and used to calculate saliva flow (ml/min) and thus IgA secretion rate (μg/min). Participants were asked to report on their diet intake (4-day food diary) before and after each supplementation phase, as well as reporting on any respiratory and gastrointestinal symptoms using a validated questionnaire. Differences between groups were analysed with one-way ANOVA on post outcome values, adjusted for outcome baseline values, and chi-squared for categorical data (SPSS software). There was a significant reduction in LBP levels in inulin compared to placebo condition (-3.15, 95%CI -5.18, -1.12; p = 0.03). Mean differences between groups (inulin vs placebo) were not significant (p> 0.10) for pH (0.43 95%CI −0.32,0.41) and IgA secretion rate (31.80 μg/min 95%CI 150.90, 87.29). Gastrointestinal symptoms were not different between groups (p>0.05), except for mild bloating/rumbling (reported in 70.8% inulin vs 44.4% placebo, p = 0.01). Respiratory symptoms were lower in inulin compared to placebo (runny nose 19.2% inulin vs 38.2%, p = 0.03). Inulin condition resulted in higher fibre intake compared to placebo, with no other differences in dietary intake (+5.43 g/day 95%CI 0.09, 10.86 p = 0.05). 90% of participants reported the intervention as acceptable and easy to follow. Inulin was well tolerated with minimal side effects of gastrointestinal bloating and rumbling. While markers of mucosal immunity did not change, intestinal permeability markers improved suggesting that in healthy populations prebiotic supplements can support gastrointestinal health but not necessarily improve mucosal immunity.

Synbiotic Intervention with Lactobacilli, Bifidobacteria, and Inulin in Healthy Volunteers Increases the Abundance of Bifidobacteria but Does Not Alter Microbial Diversity

Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults

Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics

Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial

The effect of oral synbiotics on the gut microbiota and inflammatory biomarkers in healthy adults: a systematic review and meta-analysis

A Synbiotic Formulation Comprising Bacillus subtilis DSM 32315 and L-Alanyl-L-Glutamine Improves Intestinal Butyrate Levels and Lipid Metabolism in Healthy Humans

Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity

Beneficial Effects of Synbiotics on the Gut Microbiome in Individuals with Low Fiber Intake: Secondary Analysis of a Double-Blind, Randomized Controlled Trial

A diverse high-fibre plant-based dietary intervention improves gut microbiome composition, gut symptoms, energy and hunger in healthy adults: a randomised controlled trial.

Effects of Synbiotic Lacticaseibacillus paracasei, Bifidobacterium breve, and Prebiotics on the Growth Stimulation of Beneficial Gut Microbiota

Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Evidence of the Beneficial Impact of Three Probiotic-Based Food Supplements on the Composition and Metabolic Activity of the Intestinal Microbiota in Healthy Individuals: An Ex Vivo Study

Prebiotic inulin-type fructans induce specific changes in the human gut microbiota

Effect of prebiotic supplementation in markers of intestinal permeability, pH and mucosal immunity

A Healthy Vaginal Microbiota Remains Stable during Oral Probiotic Supplementation: A Randomised Controlled Trial

Effect of Synbiotic Supplementation on Obesity and Gut Microbiota in Obese Adults: a Double-Blind Randomized Controlled Trial

Evaluating the Role of Postbiotics in the Modulation of Human Oral Microbiota: A Randomized Controlled Clinical Trial

Evaluation of synbiotic combinations of commercial probiotic strains with different prebiotics in in vitro and ex vivo human gut microcosm model

Effect of Lacticaseibacillus Paracasei K56 with Galactooligosaccharide Synbiotics on Obese Individuals: an in Vitro Fermentation Model.

A Probiotic Amylase Blend Positively Impacts Gut Microbiota Modulation in a Randomized, Placebo-Controlled, Double-Blind Study

Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, Parallel, Double-Blind, Placebo-Controlled Pilot Study